Skip to main content
Smart Investors Daily
Solventum Corporation logo

NYSE · SOLV

Solventum Corporation

Healthcare · Medical - Care Facilities

$84.50

Down-$1.30 (-1.52%)

Updated Nov 21, 2026, 7:30 AM

SID Score

6.2/10

Composite research score

Smart Money

58/100

Neutral

Market cap
14.36B
P/E ratio
9.47
Dividend yield
0.00%
52-week range
$62.38 – $94.16
Volume
658.4K
Avg. volume
1.1M

Price performance · SOLV

SOLV price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 20, 2026

SOLV closed at $84.50 after 21 trading sessions, down 1.07% for the selected period.

Last close
$84.50
Period change
-1.07%
Period low
$81.33
Period high
$90.43
Daily close
View OHLC price history
SOLV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 20, 2026$86.41$87.11$84.13$84.50658.4K
Nov 19, 2026$86.06$87.18$84.37$85.80931.21K
Nov 18, 2026$85.18$87.4098$85.11$86.48764.91K
Nov 17, 2026$88.05$88.85$86.03$86.06725.36K
Nov 16, 2026$88.56$89.83$88.56$88.65848.11K
Nov 13, 2026$89.12$89.83$87.89$89.08917.96K
Nov 12, 2026$89.07$89.61$87.5006$88.811.01M
Nov 11, 2026$89.30$90.26$88.46$88.62728.32K
Nov 10, 2026$89.64$90.57$87.90$90.081.25M
Nov 9, 2026$90.99$91.62$88.4575$90.431.29M
Nov 6, 2026$86.45$93.10$85.045$90.383.17M
Nov 5, 2026$90.34$90.50$85.565$87.181.88M
Nov 4, 2026$87.49$90.605$87.48$89.352.17M
Nov 3, 2026$84.02$85.38$83.71$84.761.01M
Nov 2, 2026$82.46$84.76$81.66$84.751.24M
Oct 30, 2026$84.15$84.48$80.76$81.331.07M
Oct 29, 2026$82.27$83.68$82.25$83.561.09M
Oct 28, 2026$83.08$83.33$81.38$81.851.57M
Oct 27, 2026$85.36$85.81$82.85$82.981.32M
Oct 26, 2026$85.68$87.56$85.68$85.81975.57K
Oct 23, 2026$86.92$87.27$84.81$85.411.66M

Latest SOLV news

The latest Smart Investors Daily articles mentioning SOLV.

SOLV research

Overview

Company profile and research snapshot.

Company profile

In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$93.33
Implied upside
—
Analysts
21
SOLV recent ratings
DateFirmRatingTarget
Nov 6, 2026Wells FargoEqual-Weight—
Nov 6, 2026Piper SandlerOverweight—
Sep 14, 2026BTIGBuy—
Aug 6, 2026WedbushOutperform—
Aug 6, 2026Piper SandlerOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 10, 2026

Solventum (SOLV) stock trades up, here is why

Shares of healthcare solutions provider Solventum (NYSE:SOLV) jumped 5% in the afternoon session after the company reported third-quarter 2026 financial results and raised its full-year adjusted earnings per share guidance.

Yahoo · Nov 9, 2026

Top Medical Supply Stock Picks From BTIG

Investing.com -- BTIG has highlighted its top pick in the medical supply sector, with analysts raising their price target on the leading stock following strong third-quarter results that exceeded expectations despite operational headwinds.

Yahoo · Nov 8, 2026

Solventum Q3 Earnings Call Highlights

Solventum (NYSE:SOLV) raised its 2026 earnings outlook after reporting third-quarter results that exceeded its expectations for organic growth and earnings, even as the reversal of advance orders weighed on sales. The health care company reported sales of $1.95 billion, down 7% from a year earlier,

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.